Phase I/II Study of Combined BCL-XL and MEK Inhibition with Navitoclax (N) and Trametinib (T) in KRAS or NRAS Mutant Advanced Solid Tumours
Ryan B. Corcoran,Khanh T. Do,Jeong E. Kim,James M. Cleary,Aparna R. Parikh,Oladapo O. Yeku,Niya Xiong,Colin D. Weekes,Jennifer Veneris,Leanne G. Ahronian,Gianluca Mauri,Jun Tian,Bryanna L. Norden,Alexa G. Michel,Emily E. Van Seventer,Giulia Siravegna,Kyle Camphausen,Gary Chi,Isobel J. Fetter,Joan S. Brugge,Helen Chen,Naoko Takebe,Richard T. Penson,Dejan Juric,Keith T. Flaherty,Ryan J. Sullivan,Jeffrey W. Clark,Rebecca S. Heist,Ursula A. Matulonis,Joyce F. Liu,Geoffrey I. Shapiro CLINICAL CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
